Dr Agarwal's Health Care Chart
Dr Agarwal's Health Care. Share Key Metrics
Volume
48797.00
Market Cap
14563.64 CR
LTQ@LTP
2@459.70
ATP
458.15
Var Margin
13.71 %
Circuit Range
365.5-548.2
Delivery %
44.78 %
Value
2.24 CR
ASM/GSM
No
Market Lot
1
Summary
Dr Agarwal's Health Care. Fundamentals
View MoreP/E Ratio
114.74
P/B Ratio
7.32
Div. Yield
0
Sector P/E
56.53
Sector P/B
-15.78
Sec. Div. Yield
0.19
Dr Agarwal's Health Care. Resistance and Support
Pivot 454.37
Resistance
First Resistance
469.29
Second Resistance
481.72
Third Resistance
496.64
Support
First Support
441.94
Second Support
427.02
Third Support
414.59
Dr Agarwal's Health Care. Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-21 | Audited Results |
| 2026-02-03 | Quarterly Results |
Dr Agarwal's Health Care. News
Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Dr. Agarwal's Health Care announced the Monitoring Agency Report for Q4 FY26, issued by ICRA Limited. The report confirmed that the utilization of IPO proceeds was in line with the objects of the issue, with no deviations observed. This indicates sound governance in fund deployment.
May 15 2026 19:05:00
Dr. Agarwals Health Care Ltd - 544350 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dr. Agarwal's Health Care will host an Earnings/Analyst Conference Call on May 21, 2026, from 06:30 P.M. IST to 07:30 P.M. IST to discuss the Annual Financial Results for Q4 FY26 and the full year ended March 31, 2026. The call will be attended by the CEO, CFO, and Head of Investor Relations.
May 14 2026 15:05:00
About Dr Agarwal's Health Care. AboutThe
NSE : 29452
BSE : 544350
ISIN : INE943P01029
Our Company was incorporated as ‘Dr. Agarwal’s Health Care Limited’ at Chennai Tamil Nadu as a public limited company under the Companies Act 1956 pursuant to the certificate of incorporation dated April 19 2010 issued by the RoC and commenced operations pursuant to the certificate for commencement of business dated May 29 2010 issued by the RoC.Major Events and Milestones:2010- Incorporation of our Company.- Entry into the Telangana (formerly a part of Andhra Pradesh) and Karnataka markets by entering into lease agreements for setting up eye clinics.2011- Investment by EILSF SPV 3 in our Company.2012- Entry into the Africa market by entering into an agreement with Dr Amelia Buque to jointly promote eye hospitals and other health care related services in Mozambique.2017- Entry into the Maharashtra market through the acquisition of hospital facilities in Maharashtra.2019- Investment by Claymore Investments (Mauritius) Pte. Ltd. an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited and Value Growth Investment Holdings Pte. Ltd in our Company through subscription of equity shares.- Subscription of NCDs by British International Investment (formerly known as CDC Group PLC) in our Company.2021- Our Company launched its 100th eye care facility.2022- Investment by TPG Capital’s Hyperion Investments Pte. Ltd. and Arvon Investments Pte. Ltd. an indirect wholly owned subsidiary of Temasek Holdings (Private) Limited in our Company through subscription of equity shares.- Entry into the Jammu market through the acquisition of Dr. Sood eye care practices from Dr. Rohan and Raj Deep Sood.- Strengthened presence in the Gujarat market through acquisition of the eye care business from Prizma Eyecare LLP Dr. Sanjay Vallabhai Savani and Dr. Ashish P. Gusani2023- Strengthened presence in the Punjab market through the acquisition of Punjab Eye Hospital from Dr. Gurpal Singh2024- Entry in the Uttar Pradesh market through the acquisition of an eye care business in Varanasi.- Expanded our presence in Punjab market by acquisition of Dr Thind Eye Care Private Limited.
Dr Agarwal's Health Care. Management
| Name | Position |
|---|---|
| Thanikainathan Arumugam | Company Secretary & Compliance Officer |
| Adil Agarwal | Whole Time Director & Chief Executive Officer |
Dr Agarwal's Health Care. Similar Stocks
Cohance Lifesciences Ltd.
420.15
-8.20 (1.91%)
Jubilant Pharmova Ltd.
1014.20
3.25 (0.32%)
Caplin Point Laboratories Ltd.
2016.60
-21.60 (1.06%)
Poly Medicure Ltd.
1459.40
4.30 (0.30%)
Alembic Pharmaceuticals Ltd.
752.35
1.25 (0.17%)
Rainbow Children's Medicare Ltd.
1342.00
-8.70 (0.64%)
Vijaya Diagnostic Centre Ltd.
1271.70
-28.40 (2.18%)
Alivus Life Sciences Ltd.
1060.80
-0.80 (0.08%)
Concord Biotech Ltd.
1116.00
-27.50 (2.40%)
Sanofi Consumer Healthcare India Ltd.
4854.40
65.00 (1.36%)
Dr Agarwal's Health Care. FAQs
